Supplementary Figure S5 from Evaluation of Biomarkers for Sacituzumab Govitecan in Metastatic Non–Small Cell Lung Cancer: Insights From the EVOKE-01 Study

Authors: Enriqueta Felip, Peiwen Kuo, Pilar Garrido et al.

Publication:

Published: Unknown date

Source: Crossref

Back to Search View Original Cite This Article

Abstract

<jats:p><p>ctDNA level (A) Methylation-based ctDNA fraction at baseline and C2D1 by treatment arm. Kaplan-Meier plots for PFS for baseline ctDNA median subgroups with (B) SG and (C) docetaxel.</p></jats:p>

Keywords

ctdna baseline pctdna level methylationbased

Supplementary Figure S5 from Evaluation of Biomarkers for Sacituzumab Govitecan in Metastatic Non–Small Cell Lung Cancer: Insights From the EVOKE-01 Study

Abstract

Keywords

Related Articles

A Participatory Dynamic Modelling Framework to Support WEFE Nexus Management: Evidence from the Segura River Basin

Complete particle physics from an exactly solvable 21-state vacuum: 27 Standard Model predictions with zero free parameters and quantum hardware validation

Application of Biopesticide Derived from (Mimosa pudica L.) Weed Extract and Trichoderma-Based Biofertilizer on Kailan Mustard (Brassica oleracea var. alboglabra)

An Empirical Constraint on the Hubble Constant from the Relation Ωᵧ = α²

Supplementary material to "Multi-decadal evolution of ice-debris complexes at Muztagh Ata (Eastern Pamir) derived from Corona KH-4A and Pléiades stereo images"